US aims to follow Britain's lead in fighting superbugs (Update)

March 4, 2014 by Kerry Sheridan

Some $30 million proposed by President Barack Obama could help hospitals fight the growing problem of antibiotic resistance much the way Britain has, US health authorities said Tuesday.

The extra funds for fiscal year 2015, if approved by Congress, would double the amount spent on efforts to cut back on overprescribing of antibiotics, a widespread trend that experts agree is contributing to dangerous superbugs and untreatable infections worldwide.

The money would help "establish a robust infrastructure that can detect antibiotic resistance threats and protect patients and communities," said Tom Frieden, chief of the US Centers for Disease Control and Prevention.

The goal is to reduce deadly infections that are often picked up by patients in hospital and long-term care settings by half in five years, he said.

Frieden also spoke to reporters about a new CDC Vital Signs report that found more than one third of antibiotics prescribed in hospitals might be unnecessary and could be fueling drug resistance.

Since prescribing practices vary widely by hospital, improved stewardship programs could help streamline practice and cut back on potential errors and excess in prescribing, he said.

"Practices that are not optimal are putting patients at unnecessary risk of future drug resistant infections," said Frieden.

"This is about hospitals getting together, agreeing on protocols and then implementing those protocols," he said.

In some hospitals, doctors prescribed three times as many antibiotics as others, even when patients were being cared for in similar areas.

"This kind of wide difference does provide a warning bell," said Frieden.

The Vital Signs report was based on data from 183 US hospitals in 2011.

More than half (55.7 percent) of the 11,282 hospital patients studied received an antibiotic to treat an active infection, it said.

"Antibiotic use could potentially have been improved" in 37 percent of cases, said the report.

The most common possible errors were doling out antibiotics without proper testing and prescribing them for too long.

Not just a theory

Cutting back on certain antibiotics could help reduce cases of potentially deadly diarrhea caused by a bacterium called Clostridium difficile, sometimes called C. diff or CDI, the report added.

A 30 percent drop in use of broad spectrum antibiotics could lead to 26 percent fewer C. difficile infections, according to CDC modeling estimates.

Infections from C. difficile are usually acquired during medical care and are linked to 14,000 US deaths annually.

If funded at $30 million per year over the next five years, Frieden said the new US initiative would aim to cut infections of C. diff and Carbapenem-resistant Enterobacteriaceae (CRE) by half over that time span.

"This isn't just a theory. We have seen systems, we have seen countries do this. And I am very confident that if we invest, we will be able to do it here."

Lead author of the Vital Signs report, Arjun Srinivasan of the US National Center for Emerging and Zoonotic Infectious Diseases, said Britain was an example for the United States to follow in this realm.

"Over the past seven years the UK has engaged in a robust effort throughout the country to reduce the use of antibiotics that are most associated with Clostridium difficile," Srinivasan said.

"What they have seen is a more than 50 percent reduction in the use of those targeted agents and they have a seen a roughly 70 percent reduction in Clostridium difficile," he said, describing the results as "very dramatic."

The Infectious Diseases Society of America applauded the proposal to boost CDC funds, but warned that years of belt-tightening have taken a toll.

"On behalf of the millions of patients who suffer from resistant infections, IDSA has long called for increased federal leadership to address this public health crisis," the group said in a statement.

"This budget request is an important step forward, and we urge Congress to fully fund it."

Explore further: Mistakes may be common in prescribing antibiotics in US

Related Stories

Mistakes may be common in prescribing antibiotics in US

March 4, 2014
More than one third of antibiotics prescribed in hospitals might be unnecessary and could be fueling drug resistance, US health authorities said Tuesday.

CDC addresses burden, threat of antibiotic resistance

January 6, 2014
(HealthDay)—The burden and threats posed by antibiotic resistance infections are discussed in a report published by the U.S. Centers for Disease Control and Prevention.

US warns over deadly, hard-to-treat bacteria (Update)

March 5, 2013
A deadly strain of hard-to-treat bacteria is spreading in US health facilities, posing a particular risk to the nation's most vulnerable patients, authorities said in a report on Tuesday.

Unnecessary antimicrobial use increases risk of recurrent infectious diarrhea

January 9, 2013
The impact of antibiotic misuse has far-reaching consequences in healthcare, including reduced efficacy of the drugs, increased prevalence of drug-resistant organisms, and increased risk of deadly infections. A new study ...

CDC sounds alarm on antibiotic-resistant bacteria

September 16, 2013
(HealthDay)—More than 2 million people come down with infections from antibiotic-resistant bacteria every year in the United States, leading to at least 23,000 deaths, according to a report released Monday by federal health ...

The threat from superbugs

February 10, 2014
As government and health officials voice growing alarm over the spread of drug-resistant bacteria around the world, a panel of experts on Wednesday recommended steps to address the problem in hospitals, in communities, and ...

Recommended for you

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

'Superbugs' study reveals complex picture of E. coli bloodstream infections

July 18, 2017
The first large-scale genetic study of Escherichia coli (E. coli) cultured from patients with bloodstream infections in England showed that drug resistant 'superbugs' are not always out-competing other strains. Research by ...

Ebola virus can persist in monkeys that survived disease, even after symptoms disappear

July 17, 2017
Ebola virus infection can be detected in rhesus monkeys that survive the disease and no longer show symptoms, according to research published by Army scientists in today's online edition of the journal Nature Microbiology. ...

Mountain gorillas have herpes virus similar to that found in humans

July 13, 2017
Scientists from the University of California, Davis, have detected a herpes virus in wild mountain gorillas that is very similar to the Epstein-Barr virus in humans, according to a study published today in the journal Scientific ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.